secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001193125-23-259994
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Nasdaq notified Sensei on Oct 17, 2023 that stock bid price <$1 for 30 consecutive days, violating Listing Rule 5450(a)(1).
- Company has 180 days (until April 15, 2024) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- Options include transferring to Nasdaq Capital Market or effecting a reverse stock split; company will monitor and consider remedies.
- If not cured within compliance periods, Nasdaq will delist shares; company may appeal to a Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523259994/0001193125-23-259994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523259994/d560954d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-259994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer